Home
Conditions
Sezary Syndrome

Clinical trial condition

Sezary Syndrome

Explore clinical trials studying Sezary Syndrome. Study availability and eligibility vary by location and protocol.

35 public trials 8 recruiting studies

Refine in advanced search Browse all conditions

Sezary Syndrome trial results

Completed

Salvia Hispanica Seed in Reducing Risk of Disease Recurrence in Patients With Non-Hodgkin Lymphoma

NCT02652715

Conditions: Adult Nasal Type Extranodal NK/T-cell Lymphoma, Adult T-Cell Leukemia/Lymphoma, Anaplastic Large Cell Lymphoma, +76 more
Locations: Mayo Clinic Rochester, Minnesota, United States

View Trial Details

Completed

Oral SAHA (Suberoylanilide Hydroxamic Acid) in Advanced Cutaneous T-cell Lymphoma (0683-001)

NCT00091559

Conditions: Cutaneous T-Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
Locations: Not specified

View Trial Details

Completed

Brentuximab Vedotin (SGN-35) in Patients With Mycosis Fungoides With Variable CD30 Expression Level

NCT01396070

Conditions: Cutaneous Lymphoma, Cutaneous T-cell Lymphoma (CTCL), Hemic and Lymphatic Diseases, +13 more
Locations: Stanford University School of Medicine Stanford, California, United States

View Trial Details

Completed

A-dmDT390-bisFv(UCHT1) Immunotoxin Therapy for Patients With Cutaneous T-Cell Lymphoma (CTCL)

NCT00611208

Conditions: Cutaneous T-cell Lymphoma (CTCL), Hematologic Diseases, Hemic and Lymphatic Diseases, +17 more
Locations: Yale University School Of Medicine Recruiting New Haven, Connecticut, United States

James Graham Brown Cancer Center Louisville, Kentucky, United States

University of Texas Southwestern Medical Center Dallas, Texas, United States

University of Texas MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Combination Drug Study of Bexarotene and Rosiglitazone to Treat CTCL

NCT00178841

Conditions: Cutaneous T-Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
Locations: Vanderbilt University Medical Center Nashville, Tennessee, United States

View Trial Details

Completed

Immunization Against Tumor Cells in Sezary Syndrome

NCT00099593

Conditions: Cutaneous T-Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
Locations: University of Pittsburgh Medical Center, Department of Dermatology Pittsburgh, Pennsylvania, United States

View Trial Details

Completed

Effect of Denileukin Diftitox on Immune System in CTCL Patients

NCT00254332

Conditions: Cutaneous T-Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
Locations: University of Pittsubrgh Medical Center Pittsburgh, Pennsylvania, United States

View Trial Details

Completed

In Vitro Evaluation of Immune Responses in Cutaneous T-Cell Lymphoma (CTCL)

NCT00177190

Conditions: Cutaneous T-Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
Locations: University of Pittsburgh Medical Center Pittsburgh, Pennsylvania, United States

View Trial Details

Completed

Killer Immunoglobulin-Like Receptor Transcripts Expression for the Diagnosis of Epidermotropic Cutaneous T Cell Lymphoma

NCT00748319

Conditions: Dermatitis, Dermatitis, Exfoliative, Disease, +18 more
Locations: Groupe hospitalier Henri Mondor - Albert Chenevier Créteil, France

View Trial Details

Completed

Study of ONTAK (Denileukin Diftitox) in Cutaneous T-Cell Lymphoma (CTCL) Patients

NCT00050999

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more
Locations: University of Texas, M.D. Anderson Cancer Center Houston, Texas, United States

Level 4 Department of Haematology Royal North Shore Hospital Saint Leonard's, New South Wales, Australia

Westmead Hospital, Department of Haematology Westmead, New South Wales, Australia

Mater Misericordiae Adult Hospital South Brisbane, Queensland, Australia

View all 35 locations

View Trial Details

Sezary Syndrome

Sezary Syndrome trial results

Related conditions